| Pharmaceutical active ingredients: |
| BudesonideFormoterol Fumarate |
| Available forms, composition and doses of Rilast: |
| N / A |
| Rilast medical category: |
| Human:AdrenalsAntiasthmatic and COPD preparationsNasal decongestants and other nasal preparationsSelective beta-2-adrenergic agonistsTopical corticosteroids used as nasal decongestants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03AK07 - Formoterol and other drugs for obstructive airway diseases |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Esteve Farma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Foracort Forte | Budesonide; Formoterol Fumarate | Cipla |
| Foracort Neo-Haler | Budesonide; Formoterol Fumarate | Cipla |
| Foraseq | Budesonide; Formoterol Fumarate | Novartis |
| Formonide Novocart | Budesonide; Formoterol Fumarate | Zydus Cadila; German Remedies |
| Neumoterol | Budesonide; Formoterol Fumarate | Phoenix Laboratorios |
| Simbicort | Budesonide; Formoterol Fumarate | AstraZeneca |
| Sinestic | Budesonide; Formoterol Fumarate | Sigma-Tau Pharmaceuticals |
| Symbicord | Budesonide; Formoterol Fumarate | AstraZeneca |
| Symbiva | Budesonide; Formoterol Fumarate | Ranbaxy |
| Symbicort | Budesonide; Formoterol Fumarate Dihydrate | AstraZeneca; Teva; Zuellig Pharma |